Published in Cancer Vaccine Week, November 28th, 2005
"3-HK is a recently characterized daphnane-type compound isolated from Dendrostellera lessertii with high antitumor activity in animal models. Herein, we report on time- and dose-dependent effects of this compound on growth, differentiation, IMPDH inhibition, cell cycle and apoptosis of a panel of human leukemia cell lines (HL-60, K562 and Molt4)," scientists writing in the International Journal of Biochemistry & Cell Biology reported.
"The drug decreased the growth of leukemia cells in <24 h of treatment. However, longer exposure times and/or higher...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Vaccine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.